Use of biomarkers in the emergency department and chest pain unit

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The use of biomarkers of cardiac injury in the emergency department (ED) and observation unit settings has several nuances that are different and, therefore, worthy of its own set of use guidelines. The markers that are used, however, are the same. The primary marker of choice continues to be cardiac troponin (Tn). Other markers that have been used because of the need in the ED for rapid triage have been myoglobin and fatty acid binding protein. In addition, some centers still prefer less sensitive and less specific markers such as creatine kinase myocardial band (CK-MB). More recently, a push has occurred to develop markers of ischemia, such as ischemia modified albumin (IMA), to determine which patients have ischemia, even in the absence of cardiac injury. As troponin assays become more sensitive and method for use becomes better understood, the use of these other markers are being relegated to lesser and lesser roles. Markers of ischemia are useful, but at present, despite some enthusiasm, are not ready for routine use. Before describing the recommendations for clinical use of biomarkers in the ED, a basic understanding of some of the science and measurement issues related to these analytes is helpful.

Original languageEnglish (US)
Pages (from-to)453-465
Number of pages13
JournalCardiology Clinics
Volume23
Issue number4
DOIs
StatePublished - Nov 2005

Fingerprint

Chest Pain
Hospital Emergency Service
Troponin
Ischemia
Biomarkers
MB Form Creatine Kinase
Fatty Acid-Binding Proteins
Myoglobin
Triage
Wounds and Injuries
Observation
Guidelines

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Use of biomarkers in the emergency department and chest pain unit. / Jaffe, Allan S.

In: Cardiology Clinics, Vol. 23, No. 4, 11.2005, p. 453-465.

Research output: Contribution to journalArticle

@article{cb85c7c7ab764d5abfa9364de1f1a6c1,
title = "Use of biomarkers in the emergency department and chest pain unit",
abstract = "The use of biomarkers of cardiac injury in the emergency department (ED) and observation unit settings has several nuances that are different and, therefore, worthy of its own set of use guidelines. The markers that are used, however, are the same. The primary marker of choice continues to be cardiac troponin (Tn). Other markers that have been used because of the need in the ED for rapid triage have been myoglobin and fatty acid binding protein. In addition, some centers still prefer less sensitive and less specific markers such as creatine kinase myocardial band (CK-MB). More recently, a push has occurred to develop markers of ischemia, such as ischemia modified albumin (IMA), to determine which patients have ischemia, even in the absence of cardiac injury. As troponin assays become more sensitive and method for use becomes better understood, the use of these other markers are being relegated to lesser and lesser roles. Markers of ischemia are useful, but at present, despite some enthusiasm, are not ready for routine use. Before describing the recommendations for clinical use of biomarkers in the ED, a basic understanding of some of the science and measurement issues related to these analytes is helpful.",
author = "Jaffe, {Allan S}",
year = "2005",
month = "11",
doi = "10.1016/j.ccl.2005.08.013",
language = "English (US)",
volume = "23",
pages = "453--465",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Use of biomarkers in the emergency department and chest pain unit

AU - Jaffe, Allan S

PY - 2005/11

Y1 - 2005/11

N2 - The use of biomarkers of cardiac injury in the emergency department (ED) and observation unit settings has several nuances that are different and, therefore, worthy of its own set of use guidelines. The markers that are used, however, are the same. The primary marker of choice continues to be cardiac troponin (Tn). Other markers that have been used because of the need in the ED for rapid triage have been myoglobin and fatty acid binding protein. In addition, some centers still prefer less sensitive and less specific markers such as creatine kinase myocardial band (CK-MB). More recently, a push has occurred to develop markers of ischemia, such as ischemia modified albumin (IMA), to determine which patients have ischemia, even in the absence of cardiac injury. As troponin assays become more sensitive and method for use becomes better understood, the use of these other markers are being relegated to lesser and lesser roles. Markers of ischemia are useful, but at present, despite some enthusiasm, are not ready for routine use. Before describing the recommendations for clinical use of biomarkers in the ED, a basic understanding of some of the science and measurement issues related to these analytes is helpful.

AB - The use of biomarkers of cardiac injury in the emergency department (ED) and observation unit settings has several nuances that are different and, therefore, worthy of its own set of use guidelines. The markers that are used, however, are the same. The primary marker of choice continues to be cardiac troponin (Tn). Other markers that have been used because of the need in the ED for rapid triage have been myoglobin and fatty acid binding protein. In addition, some centers still prefer less sensitive and less specific markers such as creatine kinase myocardial band (CK-MB). More recently, a push has occurred to develop markers of ischemia, such as ischemia modified albumin (IMA), to determine which patients have ischemia, even in the absence of cardiac injury. As troponin assays become more sensitive and method for use becomes better understood, the use of these other markers are being relegated to lesser and lesser roles. Markers of ischemia are useful, but at present, despite some enthusiasm, are not ready for routine use. Before describing the recommendations for clinical use of biomarkers in the ED, a basic understanding of some of the science and measurement issues related to these analytes is helpful.

UR - http://www.scopus.com/inward/record.url?scp=27744472902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744472902&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2005.08.013

DO - 10.1016/j.ccl.2005.08.013

M3 - Article

C2 - 16278117

AN - SCOPUS:27744472902

VL - 23

SP - 453

EP - 465

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

IS - 4

ER -